Greenstone Recalls Citalopram and Finasteride

Greenstone announced a recall of medicines labeled with the Lot # FI0510058-A because they may be mislabeled. Bottles labeled as containing citalopram may contain finasteride. This recall includes 100-count bottles of citalopram 10mg tablets and 90-count bottles of finasteride 5mg tablets.

Citalopram is indicated for the treatment of depression. Patients who discontinue citalopram abruptly by inadvertently taking the mislabeled product may experience discontinuation symptoms and/or worsening of depression. Finasteride is used for the treatment of benign prostatic hyperplasia. It should not be taken or handled by women who are, or may become, pregnant due to the risk of birth defects.

Patients who believe they may have ingested the wrong medication should contact their healthcare provider as soon as possible.

For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm248595.htm.